{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:39:43Z","timestamp":1789205983937,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.trim.2014.02.002","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T19:31:03Z","timestamp":1392751863000},"page":"107-113","source":"Crossref","is-referenced-by-count":12,"title":["Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment"],"prefix":"10.1016","volume":"30","author":[{"given":"Janette","family":"Furuzawa-Carballeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Bostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mancilla-Urrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Reyes-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Chevaile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Morales-Buenrostro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Alber\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2014.02.002_bb0005","series-title":"Annual data report: kidney","article-title":"OPTN\/SRTR","author":"Matas","year":"2011"},{"key":"10.1016\/j.trim.2014.02.002_bb0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0015","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/MNH.0b013e32834b4343","article-title":"Calcineurin inhibitors in kidney transplantation: friend or foe?","volume":"20","author":"Casey","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.trim.2014.02.002_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1432-2277.2011.01386.x","article-title":"Belatacept: from rational design to clinical application","volume":"25","author":"Wekerle","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.trim.2014.02.002_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0035","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.transproceed.2010.08.037","article-title":"High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment","volume":"42","author":"Furuzawa-Carballeda","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trim.2014.02.002_bb0040","doi-asserted-by":"crossref","first-page":"2,330","DOI":"10.1111\/j.1365-2249.2011.04504.x","article-title":"Infiltrating cellular pattern in kidney graft biopsies translates into forkead box protein 3 up-regulation and p16 INK4\u03b1+ senescence protein down-regulation in patients treated with belatacept compared to cyclosporine A","volume":"167","author":"Furuzawa-Carballeda","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.trim.2014.02.002_bb0045","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.trim.2014.02.002_bb0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u2018CAN\u2019)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0055","doi-asserted-by":"crossref","first-page":"256969","DOI":"10.1155\/2012\/256960","article-title":"Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study","volume":"2012","author":"Furuzawa-Carballeda","year":"2012","journal-title":"J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-6143.2011.03504.x","article-title":"Chronic calcineurin inhibitor nephrotoxicity \u2014 lest we forget","volume":"11","author":"Chapman","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+ CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"173","key":"10.1016\/j.trim.2014.02.002_bb0070","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting Th1 and Th17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trim.2014.02.002_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2011.01.005","article-title":"Human T cells induce their own regulation through activation of B cells","volume":"36","author":"Lemoine","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trim.2014.02.002_bb0080","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans","volume":"2010; 120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2014.02.002_bb0085","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1172\/JCI39922","article-title":"Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans","volume":"120","author":"Sagoo","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2014.02.002_bb0090","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype","volume":"78","author":"Pallier","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.trim.2014.02.002_bb0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-6143.2010.03336.x","article-title":"Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile","volume":"11","author":"Le Texier","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2014.02.002_bb0100","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/eji.201040673","article-title":"IL-10 produced by activated human B cells regulates CD4+ T-cell activation in vitro","volume":"40","author":"Bouaziz","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trim.2014.02.002_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","article-title":"Human marginal zone B cells","volume":"27","author":"Weill","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0115","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.trim.2014.02.002_bb0120","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20071555","article-title":"Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants","volume":"205","author":"Weller","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2014.02.002_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2174\/156652412800620057","article-title":"IL-10 producing regulatory B cell in mice and humans: state of the art","volume":"12","author":"Bouaziz","year":"2012","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.trim.2014.02.002_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2010.09.010","article-title":"Regulatory B cells: evidence, developmental origin and population diversity","volume":"48","author":"Vitale","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0135","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1172\/JCI45685","article-title":"Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors","volume":"121","author":"Kardava","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2014.02.002_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.imbio.2005.12.003","article-title":"Differences in CXCR4-mediated signaling in B cells","volume":"211","author":"Palmesino","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.trim.2014.02.002_bb0145","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.4049\/jimmunol.176.4.2197","article-title":"Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells","volume":"176","author":"Infantino","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0150","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2014.02.002_bb0155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.21944","article-title":"Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis","volume":"67","author":"Correale","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.trim.2014.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.humimm.2010.09.011","article-title":"Increased liver-infiltrating CD8+ FoxP3+ regulatory T cells are associated with tumour stage in hepatocellular carcinoma patients","volume":"71","author":"Yang","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/0192623311430693","article-title":"Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression","volume":"40","author":"Peterson","year":"2012","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.trim.2014.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1126\/science.1073514","article-title":"Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase","volume":"297","author":"Munn","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.trim.2014.02.002_bb0175","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/eji.200636690","article-title":"Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells","volume":"37","author":"Manlapat","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0180","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.4049\/jimmunol.172.7.4100","article-title":"Ligation of B7-1\/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells","volume":"172","author":"Munn","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0185","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1767","article-title":"Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells","volume":"10","author":"Duhen","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0190","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2014.02.002_bb0195","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trim.2014.02.002_bb0200","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trim.2014.02.002_bb0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10875-011-9540-8","article-title":"Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis","volume":"31","author":"Zhang","year":"2011","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.trim.2014.02.002_bb0210","doi-asserted-by":"crossref","first-page":"e31000","DOI":"10.1371\/journal.pone.0031000","article-title":"Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2014.02.002_bb0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1535370213477597","article-title":"IL-22+ CD4+ T-cells in patients with active systemic lupus erythematosus","volume":"238","author":"Zhao","year":"2013","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.trim.2014.02.002_bb0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/imr.12038","article-title":"CD4+ T-cell subsets in transplantation","volume":"252","author":"Liu","year":"2013","journal-title":"Immunol Rev"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327414000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327414000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T10:24:23Z","timestamp":1716546263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327414000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":44,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0966327414000082"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2014.02.002","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}